Atlas Trials

A Prospective Randomized Controlled Trial of Dual-Mobility Components in Primary THA

Clinical trial NCT03371212 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT03371212
Sponsor
Rush University Medical Center
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Serum Metal Levels, Specifically Cobalt, Chromium, and Titanium
Start date
2017-12-15
Primary completion
2035-12-01
Enrollment
52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.